Vertex Pharmaceuticals (VRTX) Inventory Average (2011 - 2026)

Vertex Pharmaceuticals has reported Inventory Average for 16 years, with the latest figure at $1.8 billion in Q2 2026.

• On a quarterly basis, Inventory Average rose 23.53% year-over-year to $1.8 billion in Q2 2026; TTM through Jun 2026 was $1.8 billion, a 23.53% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 48.76% from the prior year.
• Inventory Average was $1.8 billion for Q2 2026 at Vertex Pharmaceuticals, up from $1.7 billion in the prior quarter.
• The five-year high for Inventory Average was $1.8 billion in Q2 2026, with the low at $346.0 million in Q1 2022.
• Average Inventory Average over 5 years is $951.8 million, with a median of $819.9 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory Average increased 13.88% in 2022, then surged 70.95% in 2023.
• Over 5 years, Inventory Average stood at $424.4 million in 2022, then jumped by 68.18% to $713.8 million in 2023, then jumped by 60.08% to $1.1 billion in 2024, then soared by 45.0% to $1.7 billion in 2025, then grew by 6.58% to $1.8 billion in 2026.
• The last three Inventory Average figures came in at $1.8 billion (Q2 2026), $1.7 billion (Q1 2026), and $1.7 billion (Q4 2025), per Business Quant data.